The State of Innovation in Highly Prevalent Chronic Diseases 2019

Volume IV: Alzheimer's Disease Therapeutics

This report investigates the state of innovation for Alzheimer's drugs in the U.S. as of 2019. The report focuses on analyzing current drug candidates that are moving through the drug development pipeline. Through this analysis, the report aims to determine if Alzheimer's patient needs are being met through innovative drug development.
  • Language: English
  • Released: May 2019
Study included in Corporate Account only.
More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!